Group 1 - The company, Ailong Technology (688329.SH), announced a share buyback on October 31, 2025, through the Shanghai Stock Exchange trading system [1] - A total of 56,000 shares were repurchased, representing 0.0725% of the company's total share capital [1] - The highest price for the repurchased shares was 20.37 CNY per share, while the lowest price was 19.75 CNY per share, with a total expenditure of 1,116,560.00 CNY (excluding stamp duty and transaction fees) [1]

Group 1 - The company, Ailong Technology (688329.SH), announced a share buyback on October 31, 2025, through the Shanghai Stock Exchange trading system [1] - A total of 56,000 shares were repurchased, representing 0.0725% of the company's total share capital [1] - The highest price for the repurchased shares was 20.37 CNY per share, while the lowest price was 19.75 CNY per share, with a total expenditure of 1,116,560.00 CNY (excluding stamp duty and transaction fees) [1]

苏州艾隆科技股份有限公司 关于以集中竞价交易方式回购公司股份 的回购进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券代码：688329 证券简称：艾隆科技 公告编号：2025-053 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》的相关规定，公司在回购股份期间，应于每个月的前 3 个交易日 内公告截至上月末的回购进展情况，现将公司回购股份进展情况公告如下： 2025 年 10 月 31 日，公司通过上海证券交易所交易系统以集中竞价交易方式 累计回购公司股份 56,000 股，占公司总股本的比例为 0.0725%，回购成交的最高 价为 20.37 元/股，最低价为 19.75 元/股，支付的资金总额为人民币 1,116,560.00 元 （不含印花税、交易佣金等交易费用）。 本次回购股份符合法律法规的规定及公司的回购股份方案。 三、 其他事项 公司将严格按照《上市公司股份回购规则》《上海证券交易所上市公司自律监 管指引第 7 号——回购股份》等相关规定，在回 ...

Core Viewpoint - Suzhou Ailong Technology Co., Ltd. reported significant growth in revenue and profit for Q3 2025, driven by increased orders and policy support, indicating a strong recovery in operational performance [1][2]. Group 1: Financial Performance - The company achieved a revenue of 149 million yuan in Q3, representing a year-on-year increase of 83.53% [1]. - For the first three quarters, total revenue reached 280 million yuan, up 25.12% year-on-year, with net loss narrowing to 959,000 yuan, a significant improvement of 96.56% [2]. - The net cash flow from operating activities for the first three quarters was 52.01 million yuan, a year-on-year increase of 210.86%, indicating improved cash collection and operational efficiency [2]. Group 2: Research and Development - In Q3, the company invested 15.88 million yuan in R&D, accounting for approximately 10.66% of its revenue, focusing on core technologies and product upgrades [3]. - Cumulative R&D expenditure for the first three quarters was 37.84 million yuan, maintaining a competitive position within the industry [3]. - The company is concentrating on the development of medical devices and information technology products, particularly in anesthesia and surgical information systems, positioning itself to benefit from the increasing domestic production of smart medical devices [3]. Group 3: Financial Health - As of the end of the reporting period, the company's total assets were 13.836 billion yuan, with equity attributable to shareholders amounting to 777 million yuan, reflecting a growth of 3.17% since the beginning of the year [2]. - The total liabilities slightly decreased compared to the beginning of the year, indicating a stable financial structure [2].

Core Viewpoint - The company, Ailong Technology (688329.SH), has shown significant performance recovery in its Q3 2025 report, with substantial increases in revenue and net profit compared to the previous year [1] Financial Performance - The company's Q3 revenue reached 149 million yuan, marking an impressive year-on-year increase of 83.53% [1] - The net profit attributable to shareholders was 7.43 million yuan, reflecting a remarkable year-on-year growth of 182.09%, achieving quarterly profitability [1] Market Position and Product Coverage - Ailong Technology's products are now utilized in over 1,200 medical and health institutions across China, including more than 580 top-tier hospitals [1] - Among the top 50 ranked hospitals, over 30 have chosen Ailong's product series, indicating a strong market share and competitive position [1] Future Outlook - The company is expected to continue its performance improvement trend due to the ongoing expansion of its comprehensive product matrix and deeper overseas market penetration, alongside the wave of intelligent upgrades in medical supplies [1]

Core Insights - Elon Technology (688329.SH) reported its Q3 2025 results on October 28, 2025, highlighting a decrease in institutional investor holdings [1] Institutional Holdings - As of October 27, 2025, four institutional investors disclosed holding a total of 5.3617 million shares of Elon Technology, representing 6.95% of the total share capital [1] - The institutional investor group includes Suzhou Elon Technology Co., Ltd. - 2025 Employee Stock Ownership Plan, Ningbo Meishan Free Trade Port Area Yicheng Equity Investment Partnership (Limited Partnership), Suzhou Hefrui Tai Equity Investment Center (Limited Partnership), and Industrial and Commercial Bank of China - Dacheng CSI 360 Internet + Big Data 100 Index Securities Investment Fund [1] - Compared to the previous quarter, the total institutional holding percentage decreased by 2.25 percentage points [1] Public Fund Holdings - In the current period, one public fund, Dacheng CSI 360 Internet + Index A, reported a decrease in holdings, with a reduction percentage of 0.11% [1] - A total of 77 public funds did not disclose holdings in this period compared to the previous quarter, including notable funds such as Huaxia CSI 500 Index Enhanced A, Huaxia Pantai Mixed (LOF) A, Huaxia New Brocade Mixed A, and others [1]

Core Insights - The company reported a total revenue of 280 million yuan for Q3 2025, with a net profit attributable to shareholders of -959,000 yuan, indicating a loss [1] - The operating cash flow showed a net inflow of 52.01 million yuan, suggesting some liquidity despite the net loss [1] Financial Metrics - The latest debt-to-asset ratio stands at 42.74%, which is an increase of 0.20 percentage points from the previous quarter and 0.13 percentage points from the same period last year [3] - The gross profit margin is reported at 45.79%, reflecting a decrease of 0.21 percentage points compared to the same period last year [3] - The return on equity (ROE) is at -0.12%, indicating negative returns for shareholders [3] - The diluted earnings per share (EPS) is -0.01 yuan, further highlighting the company's financial struggles [3] - The total asset turnover ratio is 0.20 times, while the inventory turnover ratio is 1.62 times, providing insights into operational efficiency [3] Shareholder Information - The number of shareholders is 5,144, with the top ten shareholders holding a total of 38.28 million shares, accounting for 49.58% of the total share capital [3] - The top shareholders include Zhang Yinhua with 28.5 million shares and Xu Li with 10.8 million shares, among others [3]

Core Viewpoint - The company, Suzhou Ailong Technology Co., Ltd., has announced its financial results and governance changes, including the appointment of a new auditing firm and the cancellation of its supervisory board, which will be replaced by an audit committee. Financial Data - The company reported a credit impairment loss of CNY 3,781,955.80 for the first three quarters of 2025, based on expected credit losses from accounts receivable and other receivables [47]. - The company reversed contract asset impairment losses amounting to CNY 1,516,929.66 during the same period [48]. - The total impact of these impairment adjustments on the company's consolidated profit for the first three quarters of 2025 was CNY 2,265,026.14 [49]. Governance Changes - The company has proposed to cancel its supervisory board, transferring its responsibilities to the audit committee, in compliance with updated regulations [41][42]. - The company plans to revise its articles of association to reflect this governance change, including the removal of references to the supervisory board [42][43]. - The appointment of Lixin Certified Public Accountants as the auditing firm for 2025 has been approved, with an audit fee of CNY 1 million, consistent with the previous year [8][15]. Shareholder Meeting - The second extraordinary general meeting of shareholders is scheduled for November 14, 2025, to discuss the proposed governance changes and other matters [19][20]. - The meeting will utilize a combination of on-site and online voting methods [20][21].

Core Viewpoint - Ailong Technology (688329.SH) reported significant growth in its Q3 2025 financial results, indicating strong operational performance and profitability improvements [1] Financial Performance - The company's operating revenue reached 149 million yuan, representing a year-on-year increase of 83.53% [1] - Net profit attributable to shareholders was 7.43 million yuan, showing a year-on-year growth of 182.09% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 6.62 million yuan, reflecting a year-on-year increase of 160.26% [1]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本次计提及转回减值准备情况概述 根据《企业会计准则》以及公司会计政策、会计估计的相关规定，为了真实、 准确地反映公司截至 2025 年 9 月 30 日的财务状况，本着谨慎性原则，对截至 2025 年 9 月 30 日公司及子公司相关信用及资产进行了减值测试并计提了相应的 减值准备。2025 年前三季度公司计提信用减值损失及转回资产减值损失具体情 况如下： 单位：元 | 项目 | 年前三季度 2025 | 备注 | | --- | --- | --- | | | 计提及转回金额 | | | 信用减值损失 | | 应收账款坏账损失、其他应收账款坏账损失、长 | | （损失以"-" | -3,781,955.80 | 期应收账款坏账损失、一年内到期的长期应收款 | | 号填列） | | 坏账损失 | | 资产减值损失 | | | | （损失以"-" | 1,516,929.66 | 转回合同资产减值损失 | | 号填列） | | | | 合计 | -2,265,026.14 ...